Stability of probiotics with antibiotics via gastric tube by simple suspension method: An in vitro study.
Anti-Bacterial Agents
/ administration & dosage
Clostridium butyricum
/ drug effects
Colony Count, Microbial
Diarrhea
/ etiology
Drug Compounding
/ methods
Drug Therapy, Combination
/ instrumentation
Enteral Nutrition
/ instrumentation
Enterococcus faecium
/ drug effects
Humans
Probiotics
/ administration & dosage
Suspensions
Antibiotics
Clostridium butyricum
Enterococcus faecium
Probiotics
Simple suspension method
Journal
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
ISSN: 1437-7780
Titre abrégé: J Infect Chemother
Pays: Netherlands
ID NLM: 9608375
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
01
09
2018
revised:
11
04
2019
accepted:
24
04
2019
pubmed:
28
5
2019
medline:
28
1
2020
entrez:
26
5
2019
Statut:
ppublish
Résumé
Data on the stability of probiotics with antibiotics delivered via gastric tube using the simple suspension method (SSM) are limited. Therefore, we investigated bacterial survivability in probiotics treated with antibiotics prepared by the SSM in vitro. Probiotics and antibiotics were suspended in 20 mL of sterilized hot water (55 °C) and then 1-mL of the suspensions were taken each at 10, 60, 120, 180 and 360 min. Thereafter, the samples were inoculated on 3 media and cultured at 37 °C for 24 h. Survival of probiotic strains was measured in colony-forming units. The growth of Clostridium butyricum did not change without antibiotics at all experimental times, but in the case of Enterococcus faecium tended to increase. On the other hand, the viable bacterial number of C. butyricum was decreased significantly by treatment with cefdinir, tosufloxacin, clarithromycin, or azithromycin, but was not altered by levofloxacin, minocycline, or vancomycin. The viable bacterial number of E. faecium was significantly decreased by treatment with tosufloxacin, levofloxacin, minocycline, vancomycin, or azithromycin, and was significantly increased by clarithromycin. In conclusion, our results suggest that the efficacy of probiotic therapies might be reduced by the SSM when specific antibiotics are used. Moreover, antibiotics might inhibit probiotic growth, although some probiotics are spore-forming and have high minimum inhibitory concentrations. Additionally, early administration of non-spore-forming bacteria might be desirable. Therefore, when patients are administered therapy combining probiotics and antibiotics by the SSM, we should consider the characteristics of the probiotics and the administration times.
Identifiants
pubmed: 31126751
pii: S1341-321X(18)30283-6
doi: 10.1016/j.jiac.2019.04.018
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Suspensions
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
825-828Informations de copyright
Copyright © 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.